THE SINGLE BEST STRATEGY TO USE FOR UPROSERTIB

Pharmacological inhibition from the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; also known as FRAP-relevant protein (FRP1)) has emerged as being a promising system for cancer remedy that exploits artificial lethal interactions with proteins involved in DNA problems repair, overcomes resistance to other therapies and